{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:03:03Z","timestamp":1792803783838,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":946,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1111\/jth.14745","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T02:50:15Z","timestamp":1580093415000},"page":"895-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Proof of concept of a new scale for the harmonization and the standardization of the ETP\u2010based APC resistance"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9195-304X","authenticated-orcid":false,"given":"Laure","family":"Morimont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Sophie","family":"Delvigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Michel","family":"Dogn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7644-5298","authenticated-orcid":false,"given":"Jonathan","family":"Douxfils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14745_bb0010","unstructured":"European Medicines Agency. Guideline on clinical investigation of steroid contraceptives in women \u2010 EMEA\/CPMP\/EWP\/519\/98 Rev 1. 2005."},{"key":"10.1111\/jth.14745_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0038-1653788","article-title":"Sensitivity to activated protein C; influence of oral contraceptives and sex","volume":"73","author":"Henkens","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.1995.tb05323.x","article-title":"Resistance to activated protein C in healthy women taking oral contraceptives","volume":"91","author":"Olivieri","year":"1995","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1111\/jth.14745_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second\u2010 and third\u2010generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14745_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2141.1999.01302.x","article-title":"Acquired APC resistance and oral contraceptives: differences between two functional tests","volume":"105","author":"Curvers","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14745_bb0035","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low\u2010dose oral contraceptives and acquired resistance to activated protein C: a randomised cross\u2010over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/jth.14745_bb0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0037-1613029","article-title":"Effects of (pre\u2010)analytical variables on activated protein C resistance determined via a thrombin generation\u2010based assay","volume":"87","author":"Curvers","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613145","article-title":"Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation\u2010based APC resistance test","volume":"88","author":"Curvers","year":"2002","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1111\/jth.14745_bb0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation\u2010based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14745_bb0055","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1538-7836.2004.00894.x","article-title":"Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives","volume":"2","author":"Alhenc\u2010Gelas","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0060","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1160\/TH04-11-0762","article-title":"Effect of oral contraceptives on the anticoagulant activity of protein S in plasma","volume":"93","author":"Koenen","year":"2005","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1111\/jth.14745_bb0065","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1160\/TH07-07-0439","article-title":"Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography","volume":"98","author":"Tchaikovski","year":"2007","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1111\/jth.14745_bb0070","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1538-7836.2012.04720.x","article-title":"Sex hormone\u2010binding globulin as a marker for the thrombotic risk of hormonal contraceptives","volume":"10","author":"Raps","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0075","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/jth.12172","article-title":"Resistance to APC and SHBG levels during use of a four\u2010phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial","volume":"11","author":"Raps","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross\u2010over study on the effects of levonorgestrel\u2010 and desogestrel\u2010containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0085","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second\u2010 and third\u2010generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.14745_bb0090","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1538-7836.2004.00983.x","article-title":"Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate","volume":"2","author":"Van Vliet","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/AOG.0b013e3181626d1b","article-title":"Effects of oral and transdermal hormonal contraception on vascular risk markers","volume":"111","author":"Johnson","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1111\/jth.14745_bb0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/humrep\/deh612","article-title":"Association between sex hormone\u2010binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens","volume":"20","author":"van Vliet","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1111\/jth.14745_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","year":"2003","journal-title":"Contraception"},{"key":"10.1111\/jth.14745_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2007.10.004","article-title":"Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables","volume":"77","author":"Kluft","year":"2008","journal-title":"Contraception"},{"key":"10.1111\/jth.14745_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/11591200-000000000-00000","article-title":"Hemostatic effects of a novel estradiol\u2010based oral contraceptive: an open\u2010label, randomized, crossover study of estradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel","volume":"11","author":"Klipping","year":"2011","journal-title":"Drugs R D"},{"key":"10.1111\/jth.14745_bb0120","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.thromres.2014.09.008","article-title":"Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone\u2010containing oral contraceptives","volume":"134","author":"Tchaikovski","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14745_bb0125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.contraception.2017.01.001","article-title":"Endogenous thrombin potential changes during the first cycle of oral contraceptive use","volume":"95","author":"Westhoff","year":"2017","journal-title":"Contraception"},{"key":"10.1111\/jth.14745_bb0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta\u2010oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"Agren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1111\/jth.14745_bb0135","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1160\/TH10-05-0327","article-title":"Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate\/17beta\u2010estradiol, compared with those of levonorgestrel\/ethinyl estradiol. A double\u2010blind, randomised study","volume":"105","author":"Gaussem","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0140","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.thromres.2012.07.017","article-title":"Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study","volume":"130","author":"Dargaud","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14745_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2014.12.015","article-title":"Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma","volume":"136","author":"Perrin","year":"2015","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14745_bb0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1515\/cclm-2019-0471","article-title":"Validation and standardization of the ETP\u2010based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need","volume":"58","author":"Douxfils","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.14745_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00001721-199701000-00006","article-title":"Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC\u2010resistant individuals","volume":"8","author":"Nicolaes","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14745_bb0160","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1055\/s-0038-1648978","article-title":"Laboratory diagnosis of APC\u2010resistance: a critical evaluation of the test and the development of diagnostic criteria","volume":"72","author":"de Ronde","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0165","series-title":"Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions","year":"2016"},{"key":"10.1111\/jth.14745_bb0170","series-title":"Quality in Laboratory Hemostasis and Thrombosis","first-page":"12","article-title":"Hemostasis test validation, performance, and reference intervals: international recommendations and guidelines","author":"Marlar","year":"2013"},{"key":"10.1111\/jth.14745_bb0175","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1365-2141.2002.03957.x","article-title":"Increased resistance to activated protein C after short\u2010term oral hormone replacement therapy in healthy post\u2010menopausal women","volume":"119","author":"Post","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14745_bb0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.thromres.2008.04.022","article-title":"Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross\u2010over study","volume":"123","author":"Fleischer","year":"2009","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14745_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/1354750X.2016.1204010","article-title":"Sex hormone\u2010binding globulin and thrombin generation in women using hormonal contraception","volume":"22","author":"Hugon\u2010Rodin","year":"2017","journal-title":"Biomarkers"},{"key":"10.1111\/jth.14745_bb0190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/AOG.0b013e3181626d1b","article-title":"Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial","volume":"111","author":"Johnson","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1111\/jth.14745_bb0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0037-1612973","article-title":"Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation","volume":"87","author":"Kemmeren","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.contraception.2016.08.018","article-title":"Reduced hemostatic effects with drospirenone\u2010based oral contraceptives containing estetrol vs. ethinyl estradiol","volume":"95","author":"Kluft","year":"2017","journal-title":"Contraception"},{"key":"10.1111\/jth.14745_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206376","article-title":"The effects of oral contraceptive usage on thrombin generation and activated protein C resistance in Saudi women, with a possible impact of the body mass index","volume":"13","author":"Mohamed","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.14745_bb0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","year":"2003","journal-title":"Contraception"},{"key":"10.1111\/jth.14745_bb0215","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1538-7836.2008.02863.x","article-title":"Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor","volume":"6","author":"van Vliet","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.thromres.2009.11.012","article-title":"Standardisation of thrombin generation test\u2013which reference plasma for TGT? An international multicentre study","volume":"125","author":"Dargaud","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14745_bb0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2007.06785.x","article-title":"Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study","volume":"139","author":"Dargaud","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14745_bb0230","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1111\/jth.12012","article-title":"Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method","volume":"10","author":"Loeffen","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0235","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/jth.14470","article-title":"Assessment of the analytical performances and sample stability on ST Genesia system using the STG\u2010DrugScreen application","volume":"17","author":"Douxfils","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0240","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/rth2.12238","article-title":"Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability","volume":"3","author":"Calzavarini","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0245","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1538-7836.2010.03953.x","article-title":"The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy","volume":"8","author":"Bagot","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14745_bb0250","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","article-title":"Thrombin generation assay and its application in the clinical laboratory","volume":"62","author":"Tripodi","year":"2016","journal-title":"Clin Chem"},{"key":"10.1111\/jth.14745_bb0255","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.thromres.2014.04.010","article-title":"Evaluation of pre\u2010analytical variables in a commercial thrombin generation assay","volume":"134","author":"Rodgers","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14745_bb0260","unstructured":"European Medicines Agency. Assessment report for combined hormonal contraceptives containing medicinal products\u2010EMA\/739865\/2013. 2014."}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14745","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14745","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14745","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622002902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622002902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:27:47Z","timestamp":1761535667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622002902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1538783622002902"],"URL":"https:\/\/doi.org\/10.1111\/jth.14745","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proof of concept of a new scale for the harmonization and the standardization of the ETP\u2010based APC resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}